Our lab investigates how lipid metabolism and mitochondrial function contribute to metabolic dysfunction–associated steatotic liver disease (MASLD). We explore how mitochondrial fusion proteins, such as Mfn2, regulate phospholipid homeostasis and influence disease progression toward metabolic dysfunction–associated steatohepatitis (MASH).
Beyond liver disease, we also study how the menstrual cycle and exercise impact lipid metabolism and overall metabolic health. Our goal is to uncover novel molecular targets to improve metabolic function and prevent chronic diseases.